Q: Hi, Pat. What do you think of Moderna as a stock to buy, especially in light of the new Omicron variant of COVID-19? Thanks.

A: Moderna Inc., $272.83, symbol MRNA on Nasdaq (Shares outstanding: 405.4 million; Market cap: $107.6 billion; www.modernatx.com), develops messenger RNA (ribonucleic acid) vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases.

However, the Cambridge, Massachusetts-based company is best known for its… Read More